BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Crinetics Pharmaceuticals, Inc. (CRNX)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-14
10:11 am
Sale		 2023-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX		 BIOTECHNOLOGY VALUE FUND L P 0
0.000%		 -2,736,613decrease
(Position Closed)		 Filing
2023-02-14
11:58 am
Sale		 2022-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX		 BIOTECHNOLOGY VALUE FUND L P 2,736,613
5.100%		 -267,266decrease
(-8.90%)		 Filing
2021-10-29
4:29 pm
Purchase		 2021-10-21 13G Crinetics Pharmaceuticals, Inc.
CRNX		 BIOTECHNOLOGY VALUE FUND L P 3,003,879
6.500%		 3,003,879increase
(New Position)		 Filing